Andrew Scott Paulson
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 21
- Colorectal Cancer Treatments and Studies 15
- Lung Cancer Research Studies 11
- Cancer Immunotherapy and Biomarkers 10
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 12
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
-
- Gastric Cancer Management and Outcomes 9
- Pathology and Forensic Medicine top 10%
-
- Fibroblast Growth Factor Research 7
- Co-authors
- Eric Van CutsemDavide MelisiAdrian MurphyHui‐Ling ZhenDo‐Youn OhMitesh J. BoradAntoine HollebecqueGina M. Vaccaro
- Cited by
- OncologyCancer ResearchSurgery
- Partner nations
- United StatesFranceBelgium
In The Last Decade
Andrew Scott Paulson
52 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 1.2k
- Cancer Research 376
- Surgery 917
- Pulmonary and Respiratory Medicine 552
- Pathology and Forensic Medicine 215
Countries citing papers authored by Andrew Scott Paulson
This map shows the geographic impact of Andrew Scott Paulson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Scott Paulson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Scott Paulson more than expected).
Fields of papers citing papers by Andrew Scott Paulson
This network shows the impact of papers produced by Andrew Scott Paulson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Scott Paulson. The network helps show where Andrew Scott Paulson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Scott Paulson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 44 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 14 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 0 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 1 | |
| 17 | Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 studybreakdown → | 2020 | 975 |
| 18 | 2013 | 227 | |
| 19 | 2012 | 17 | |
| 20 | 2004 | 3 |
About Andrew Scott Paulson
Andrew Scott Paulson is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (21 papers), Colorectal Cancer Treatments and Studies (15 papers), Cancer Genomics and Diagnostics (12 papers), Lung Cancer Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Gastric Cancer Management and Outcomes (9 papers) and Fibroblast Growth Factor Research (7 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (376 citations) and Surgery (917 citations). Andrew Scott Paulson has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Eric Van Cutsem, Davide Melisi, Adrian Murphy, Hui‐Ling Zhen, Do‐Youn Oh, Mitesh J. Borad, Antoine Hollebecque, Gina M. Vaccaro, Daniel V.T. Catenacci and Christine Lihou. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.